Navigation Links
IDEXX Laboratories Announces Catalyst Dx(R) Placement Total for 2009 and Installed Base of SmartService(TM) Customers
Date:1/11/2010

WESTBROOK, Maine, Jan. 11 /PRNewswire-FirstCall/ -- IDEXX Laboratories, Inc. (Nasdaq: IDXX), announced today that it placed in excess of 2,000 Catalyst Dx® chemistry analyzers in 2009, bringing the installed base to nearly 2,800. Catalyst Dx, introduced in the first quarter of 2008, is a next generation chemistry instrument that adds to the IDEXX VetLab® integrated suite of analyzers and significantly expands the range and capability of the veterinary practice's in-house diagnostic laboratory.

The Company also announced that its installed base of IDEXX SmartService(TM) customers had grown to over 2,000. SmartService provides veterinary practices using the IDEXX VetLab suite of instruments with proactive, secure service and support over the Internet, reducing potential instrument downtime while improving practice work flow.

"We are very pleased with the strength of our Catalyst Dx placements during the fourth quarter, which exceeded our expectations from October," said Jonathan Ayers, Chief Executive Officer. "We also are excited about the growth in SmartService installations, as SmartService allows us to provide better and faster service and updates to our IDEXX VetLab customers. Both Catalyst Dx and SmartService support our objective to provide products and services that help veterinary practices offer a higher standard of care and improve their businesses."

As previously announced, IDEXX Laboratories is participating in the J.P. Morgan 28th Annual Healthcare Conference in San Francisco, California and will be making a presentation today about the business, including the items disclosed in this press release.

About IDEXX Laboratories

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with
'/>"/>

SOURCE IDEXX Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmaron Expands Portfolio of Services with Acquisition of Bridge Laboratories China
2. Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories New Drug Application (NDA) for Efavirenz Tablets
3. Caraco Pharmaceutical Laboratories, Ltd. Markets Nicardipine Hydrochloride Injection
4. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
5. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution
6. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution
7. Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group
8. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010
9. MO BIO Laboratories, Inc. Launches LifeGuard(TM) Soil Preservation Solution
10. Pharmatek Laboratories Announces Acquisition of the First Xcelodose(R) 600S System on the West Coast
11. Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)...  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ) ("Juniper" ... three-month period ended March 31, 2015. First quarter financial highlights ... increase of 19% as compared to $7.0 million in ... increased 41% year-over-year, enabled by the return of normalized ... in the fourth quarter of 2014; , Service ...
(Date:5/6/2015)... , May 6, 2015 ... therapy with dolutegravir and rilpivirine   ... a Phase III clinical trial programme to evaluate ... rilpivirine (Edurant® [1] ) as maintenance therapy for ... comprises two replicate studies evaluating 48 week viral ...
(Date:5/6/2015)... Woodford Patient Capital Trust ... and the Bill & Melinda Gates Foundation to ... leading monoclonal antibody biopharmaceutical company, announced today that ... to complete a US$90 million Series B financing. ... Patient Capital Trust plc (LSE:WPCT,"Woodford") and Malin Corporation ...
Breaking Medicine Technology:Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 2Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 3Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 5Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 6Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 7Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 8Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 9Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 10Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 11ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 2ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 3ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 4ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 5ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 6ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 7ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 8ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 9ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 10Kymab Secures US$90 Million Funding 2Kymab Secures US$90 Million Funding 3Kymab Secures US$90 Million Funding 4
(Date:5/6/2015)... Norcross, GA (PRWEB) May 06, 2015 ... has chosen Hexagon Geospatial technology to manage and distribute ... , Australia is one of the driest continents on ... supply through times of drought and erratic seasonal rainfalls ... water supply solutions. , Water NSW manages raw water ...
(Date:5/6/2015)... Mateo, Calif. (PRWEB) May 06, 2015 ... SafeMonk today announced a strategic partnership to help ... the cloud. The two industry-leading companies are teaming up ... platform. , “We’re thrilled to welcome SafeMonk ... to us that the people behind SafeMonk, the global ...
(Date:5/6/2015)... 2015 National Physical Fitness and Sports ... within the U.S. Department of Health and Human Services ... Fitness and Sports Month. It is dedicated to ... to health. Throughout the month of May, Americans ... fit. , The HHS details the benefits of regular ...
(Date:5/6/2015)... May 06, 2015 Most people in the ... nursing or other care after age 65. But less than ... for it or even talking about it, reports the May ... people risk two problems. One is losing control over the ... families," says Dr. David Grabowski, a professor of health care ...
(Date:5/6/2015)... Herndon, VA (PRWEB) May 06, 2015 ... its CIT GAP Funds has invested in e-Kare, Inc. ... speeds the assessment and monitoring of chronic wounds. , ... burn, and complex surgical wounds that affect over 6.5 ... in 2013 as a spin-off enterprise from the Children’s ...
Breaking Medicine News(10 mins):Health News:Water NSW Unlocks Imagery and Elevation Data Archive Across the Enterprise using Hexagon Geospatial Solutions 2Health News:Water NSW Unlocks Imagery and Elevation Data Archive Across the Enterprise using Hexagon Geospatial Solutions 3Health News:Sookasa Grows Globally With SafeMonk Partnership 2Health News:Sookasa Grows Globally With SafeMonk Partnership 3Health News:Narconon Arrowhead Issues Guide for Physical Fitness and Sports Month 2Health News:Narconon Arrowhead Issues Guide for Physical Fitness and Sports Month 3Health News:Start Planning Now for Long-Term Care, from the May 2015 Harvard Health Letter 2Health News:CIT GAP Funds Invests in e-Kare 2Health News:CIT GAP Funds Invests in e-Kare 3
... 20 MCG Capital,Corporation (Nasdaq: MCGC ) today ... support the acquisition of Gould & Lamb, LLC by ... services company that is unique to,the workers, compensation industry. ... the workers, compensation industry,since 2001. Having completed in excess ...
... Hospitals are dangerous,places and the danger is even greater ... temps are relied on more than usual, and the ... McCaughey, Ph.D., Chairman of the Committee to Reduce Infection,Deaths, ... that hospital staff are eager to improve your safety ...
... DRAXIMAGE strong competitive position in ... Dec. 20 /PRNewswire-FirstCall/ - DRAXIMAGE, the,radiopharmaceutical division ... has appointed GE Healthcare, an industry leader ... DRAXIMAGE(R) Sestamibi in the United,States. DRAXIMAGE(R) Sestamibi ...
... 10 Law Offices of Howard G. Smith,announces ... be a lead plaintiff in,the securities class action ... common stock of Threshold Pharmaceuticals, Inc. ("Threshold,Pharmaceuticals" or ... 2005,and July 14, 2006 (the "Class Period"), including ...
... XCPT, LLC has entered into a,representation agreement ... dentists throughout the world. XCPT,s software is ... recognizing the importance of visual learning during,treatment planning. ... step of the,dental treatment process as the clinician ...
... Calif., Aug. 10 Mike Huckabee,will be the keynote ... at the Disneyland(R) Hotel in Anaheim, CA. The,event will ... "We are very honored to have a national ... who understands the importance of,Christian higher education as our ...
Cached Medicine News:Health News:MCG Capital Invests in Gould & Lamb 2Health News:How to Survive an Unexpected Trip to the Hospital During Christmas and New Years 2Health News:DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA 2Health News:DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA 3Health News:DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA 4Health News:DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA 5Health News:DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA 6Health News:DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA 7Health News:Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Threshold Pharmaceuticals, Inc. 2Health News:XCPT(TM) Patient Engagement and Communication Software Signs Representation Agreement with Lifecore Biomedical, Inc. (Nasdaq: LCBM) 2Health News:Presidential Candidate and Former Arkansas Governor Mike Huckabee to Be Keynote Speaker for Hope International University's 'Celebrate Hope' Dinner at Disneyland(R) Hotel 2
The new TOPCON 8800 Series of auto refractors and auto kerato-refractors satisfies the needs of today's demanding eyecare practice !...
The perfect tool to prepare for in-service or licensing exams, for recertification, or for use as a clinical refresher....
... Med TruFlow™ Oxygen flowmeter with a Lexan®inner ... covering calibration and manufacturing defects. A wide ... most needs. Also available with all popular ... take-off and double unit configurations. Our extra ...
... TruFlow™ Oxygen flowmeter with a Lexan®inner calibrated ... calibration and manufacturing defects. A wide range ... needs. Also available with all popular inlet ... and double unit configurations. Our extra large ...
Medicine Products: